Pharma and Biotech
US FDA ODD Application Submitted for NXP002 | 11-Aug-2025 | 07:00 | RNS |
Total Voting Rights | 30-May-2025 | 14:24 | RNS |
Confirmation of European ODD for NXP002 | 29-May-2025 | 07:00 | RNS |
Publication of a Prospectus | 23-May-2025 | 13:08 | RNS |
£210,000 Placing | 22-May-2025 | 07:00 | RNS |
Half-year Report | 02-May-2025 | 07:00 | RNS |
Confirmation of European Orphan Drug Designation | 30-Apr-2025 | 07:00 | RNS |
Change of Registered Office and Company Secretary | 29-Apr-2025 | 07:00 | RNS |
Exercise of Warrants | 14-Apr-2025 | 07:00 | RNS |
NXP002 Update | 09-Apr-2025 | 07:00 | RNS |
Result of AGM | 20-Mar-2025 | 11:10 | RNS |
Total Voting Rights | 28-Feb-2025 | 12:30 | RNS |
Posting of Annual Report and Notice of AGM | 14-Feb-2025 | 14:18 | RNS |
£168,750 Placing | 30-Jan-2025 | 07:00 | RNS |
Annual Results for period ended 30 September 2024 | 29-Jan-2025 | 07:00 | RNS |
Currency | UK Pounds |
Share Price | 0.088p |
Change Today | 0.008p |
% Change | 10.00 % |
52 Week High | 0.18p |
52 Week Low | 0.048p |
Volume | 30,672,062 |
Shares Issued | 1,995.71m |
Market Cap | £1.76m |
Beta | 0.04 |
RiskGrade | 322 |
Value |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
---|
Price Trend |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
---|
Income | ![]() |
---|
Growth | ![]() |
---|
No dividends found |
Time | Volume / Share Price |
16:40 | 295,346 @ 0.088p |
16:40 | 1,228 @ 0.088p |
16:40 | 1 @ 0.088p |
16:40 | 294,117 @ 0.088p |
16:03 | 32,022 @ 0.085p |
You are here: research